Drug-resistant tuberculosis: pediatric guidelines

Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the lite...

Full description

Saved in:
Bibliographic Details
Published inThe Pediatric infectious disease journal Vol. 30; no. 6; p. 501
Main Authors Al-Dabbagh, Mona, Lapphra, Keswadee, McGloin, Rumi, Inrig, Kelsey, Schaaf, H Simon, Marais, Ben J, Sauve, Laura, Kitai, Ian, Kollmann, Tobias R
Format Journal Article
LanguageEnglish
Published United States 01.06.2011
Subjects
Adolescent
Antitubercular Agents - pharmacology
Antitubercular Agents - therapeutic use
Child
Child, Preschool
Drug Therapy, Combination - methods
Humans
Infant
Infant, Newborn
Mycobacterium tuberculosis - drug effects
Mycobacterium tuberculosis - isolation & purification
Pediatrics - methods
Tuberculosis, Multidrug-Resistant - diagnosis
Tuberculosis, Multidrug-Resistant - drug therapy
Online AccessGet more information

Cover

More Information
Summary:Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting.
ISSN:1532-0987
DOI:10.1097/INF.0b013e31820b583d